DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
” - 4 “ - 2 it’s - 2 Eli Lilly - 2 Zepbound - 2 Rachel Batterham - 2 Wes Streeting - 2 Streeting - 2
Top related locs:
Europe Chan Baltimore WeightWatchers GLP Lilly British Brooklyn
Top related orgs:
CNN - 3 US Centers for Disease Control - 2 LONDON - 2 U.K - 2 Social - 2 Department for Science - 2 Innovation - 2 Technology - 2

Search resuls for: "Diabetes Prevention"


6 mentions found


☆ Dark chocolate linked to lower risk of type 2 diabetes, study says
  + stars: | 2024-12-04 | by ( Sandee Lamotte | ) edition.cnn.com   time to read: +6 min
CNN —Eating at least five tiny servings of dark chocolate each week may lower the risk of developing type 2 diabetes by 21%, according to a new observational study. The study found eating milk chocolate was linked to excessive weight gain over time, a key contributor to the development of type 2 diabetes. Researchers then looked at dark chocolate, milk chocolate and total chocolate consumption among over 111,000 chocolate aficionados. However, when the types of chocolate were factored in, the data showed no significant reduction in diabetes risk when consuming milk chocolate. “For anyone who loves chocolate,” Liu said, “this is a reminder that making small choices, like choosing dark chocolate over milk chocolate, can make a positive difference to their health.”
Persons: ”, Binkai Liu, Harvard T.H, Liu, Nestoras Mathioudakis, Mathioudakis, I’m, ” Mathioudakis, “, it’s, ” Liu Organizations: CNN, Harvard, of Public Health, Diabetes Prevention, Johns Hopkins Medicine, US Centers for Disease Control, Drivers, Nurses, Health Locations: Chan, Baltimore
☆ Weight loss care is leading IPO-hopeful Omada Health's latest growth surge as Ozempic boom continues
  + stars: | 2024-10-29 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +6 min
The startup says care for GLP-1 patients has become its most popular front door for new customers. AdvertisementLast spring, diabetes startup Omada Health said it wanted to help employers manage patients taking a blockbuster new class of weight-loss drugs. Omada Health's metabolic health program has now become the entry point for most new employers considering contracts with Omada Health, Duffy said. Launched in 2011, Omada provides virtual care for diabetes, hypertension, musculoskeletal care, and diabetes prevention, alongside obesity, to employers, health plans, and even health systems. The firm said GLP-1 drugs for obesity account for about 10% of all pharmacy spending.
Persons: —, Duffy, Omada, haven't, buzzy, Willis Towers Watson Organizations: Service, Omada Health, Business, Nordisk's Ozempic Locations: WeightWatchers, GLP
☆ Eli Lilly to trial use of weight loss drugs to combat unemployment in U.K.
  + stars: | 2024-10-16 | by ( Karen Gilchrist | Karen Gilchrist Is A Reporter For Cnbc.Com. | ) www.nbcnews.com   time to read: +4 min
LONDON — U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K. The weight-loss treatment firm and creator of Zepbound announced Monday that it would commit £279 million ($364 million) to help tackle Britain’s significant health challenges — including obesity. Within that, the five-year trial, conducted in collaboration with Health Innovation Manchester, will also explore how weight-loss drugs impact “participants’ employment status and sick days from work,” the company said in a news release. The use cases for obesity drugs have been growing over recent months, with several drug regulators expanding GLP-1 drug labels for use in treating obesity-related comorbidities and other illnesses. The company said it anticipates making an additional £279 million of new investment into the U.K. over the coming years.
Persons: Eli Lilly, Zepbound, ”, Rachel Batterham, Wes Streeting, Streeting, “ It’s, ” Streeting, Peter Verdault, “, Dr, Dolly van Tulleken, Eli Lilly’s Organizations: LONDON, U.K, of Health, Social, Department for Science, Innovation, Technology, Labour government’s, Investment, National Health Services, Health Innovation, International Medical, British Health, Social Care, Covid, NHS can’t, CNBC, Citi, MRC, University of Cambridge, BBC Radio, Lilly, Labs Locations: Lilly, British, Europe
☆ Eli Lilly to trial use of weight loss drugs to combat unemployment in UK
  + stars: | 2024-10-15 | by ( Karen Gilchrist | ) www.cnbc.com   time to read: +4 min
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024. LONDON — U.S. pharmaceutical giant Eli Lilly is exploring whether obesity drugs could be used to curb joblessness after signing a major investment deal with the U.K. The use cases for obesity drugs have been growing over recent months, with several drug regulators expanding GLP-1 drug labels for use in treating obesity-related comorbidities and other illnesses. Speaking to CNBC last week, Citi pharmaceuticals analyst Peter Verdault said the body of evidence to support increased use of weight-loss drugs "keeps coming." The company said it anticipates making an additional £279 million of new investment into the U.K. over the coming years.
Persons: Eli Lilly, Zepbound, Rachel Batterham, Lilly, Wes Streeting, Covid, Streeting, Peter Verdault, Dolly van Tulleken, Eli Lilly's Organizations: LONDON, U.K, Department of Health, Social, Department for Science, Innovation, Technology, Labour government's, Investment, National Health Services, Health Innovation, International Medical, Social Care, CNBC, Citi, MRC, University of Cambridge, BBC Radio, Lilly Locations: Brooklyn, New York, Europe
☆ Walking pace could impact diabetes risk, study finds
  + stars: | 2023-11-28 | by ( Kristen Rogers | ) edition.cnn.com   time to read: +5 min
Brisk walking is associated with a nearly 40% lower risk of developing type 2 diabetes later in life, according to the study published Tuesday in the British Journal of Sports Medicine. But prior findings haven’t offered much guidance on the optimal habitual walking speed needed to lower diabetes risk, and comprehensive reviews of the evidence are lacking, the authors said. Going a certain pace during your walk may help lower your type 2 diabetes risk, according to a new study. Walking at a “fairly brisk” pace meant a 24% lower risk than those who easily or casually walked. Each kilometer increase in walking speed above brisk was associated with a 9% lower risk of developing the disease.
Persons: it’s, — it’s, ”, Ahmad Jayedi, haven’t, Robert Gabbay, Gabbay wasn’t, Carmen Cuthbertson, wasn’t, Gabbay, Dr, Michio Shimabukuro, Shimabukuro wasn’t, Borja del Pozo Cruz, ” del Pozo Cruz, ” Gabbay Organizations: CNN’s, CNN, British, of Sports Medicine, Health Research Center, Semnan University of Medical Sciences, American Diabetes Association, East Carolina University, Fukushima Medical University School of Medicine, University of Cadiz, US Centers for Disease Control Locations: Iran, United States, United Kingdom, Japan, Spain
☆ Why it’s nutty not to eat nuts for good health
  + stars: | 2023-10-02 | by ( Carolyn O Neil | ) edition.cnn.com   time to read: +8 min
Sign up for CNN’s Eat, But Better: Mediterranean Style newsletter, an eight-part series that guides you in an expert-backed eating lifestyle that’s good for your health. Nuts contain dietary fiber, plant-based protein, vitamin E and potassium, calcium and magnesium. And to reap the most benefits, it’s key to make eating nuts a habit over the long haul. “Many healthy eating patterns, such as the renowned Mediterranean diet, include nuts on a regular basis in the diet,’’ Palmer said. Think outside the bowlIt’s easy to snack on nuts as part of a healthy lifestyle, but I also use nuts in many recipes.
Persons: they’re, ”, Sharon Palmer, Julio Ricco, iStockphoto, Pecans, They’re, ” Palmer, ’ Palmer, dill, Candice Bell, Liz Weiss, ” Carolyn O’Neil Organizations: CNN, US Food and Drug Administration, FDA, Beat Diabetes, ”
0 next >>
Total: 6